Development Pipeline

Finding the Most Effective Antibodies

Trellis is applying its antibody discovery technology to discovering its own pipeline of antibody therapeutics. The company has assembled a pipeline of four programs in infectious disease and oncology. RSV is the lead program and is at lead optimization stage. Once a lead has been selected, the program will progress into IND enabling studies followed by an IND filing.

 

  • Disease
  • Target Validation
  • Lead Identification
  • Lead Optimization
  • IND Enabling Studies
  • RSV
  • X
  • X
  • X
  • Oncology 1
  • X
  • X
  • Oncology 2
  • X
  • Infectious Disease 2
  • X

Trellis Bioscience, Inc.
2-B Corporate Drive
South San Francisco, CA 94080
tel 650.616.1100

Directions to Trellis Bioscience